LUNGSEARCH: Lung Cancer Screening, Early Detection, Biomarkers and New Therapeutic Targets
SEARCH
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas MD Anderson Cancer Center (17)
2020
-
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1879-1895
2019
-
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Thorax, Vol. 74, Núm. 4, pp. 371-379
-
Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
Acta neuropathologica communications, Vol. 7, Núm. 1, pp. 64
-
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Nature Communications, Vol. 10, Núm. 1
-
Tmprss4: A novel tumor prognostic indicator for the stratification of stage ia tumors and a liquid biopsy biomarker for nsclc patients
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib
American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer
Laboratory Investigation, Vol. 98, Núm. 12, pp. 1562-1574
2015
2014
-
RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner
Molecular Oncology, Vol. 8, Núm. 2, pp. 196-206
-
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
British Journal of Cancer, Vol. 110, Núm. 6, pp. 1545-1551
2012
-
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung
Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1129-1136
-
Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma
American Journal of Respiratory and Critical Care Medicine, Vol. 186, Núm. 1, pp. 96-105
2011
-
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance
Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166
2010
-
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465
2007
-
Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors
Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337
2004
-
Mitochondrial DNA Mutation at the D310 (Displacement Loop) Mononucleotide Sequence in the Pathogenesis of Gallbladder Carcinoma
Clinical Cancer Research, Vol. 10, Núm. 3, pp. 1041-1046